First-in-human evaluation of [11C]PS13, a novel PET radioligand, to quantify cyclooxygenase-1 in the brain
Author(s) -
Min-Jeong Kim,
JaeHoon Lee,
Fernanda Juarez Anaya,
Jinsoo Hong,
William H. Miller,
Sanjay Telu,
Prachi Singh,
Michelle Cortes,
Katharine Henry,
George Tye,
Michael P. Frankland,
Jose A. Montero Santamaria,
Jeih-San Liow,
Sami S. Zoghbi,
Masahiro Fujita,
Victor W. Pike,
Robert B. Innis
Publication year - 2020
Publication title -
european journal of nuclear medicine and molecular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.313
H-Index - 163
eISSN - 1619-7089
pISSN - 1619-7070
DOI - 10.1007/s00259-020-04855-2
Subject(s) - radioligand , cyclooxygenase , medicine , human brain , radioligand assay , pharmacology , nuclear medicine , chemistry , receptor , biochemistry , psychiatry , enzyme
This study assessed whether the newly developed PET radioligand [ 11 C]PS13, which has shown excellent in vivo selectivity in previous animal studies, could be used to quantify constitutive levels of cyclooxygenase-1 (COX-1) in healthy human brain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom